Svar på skriftligt spörsmål om FPA-ersättning för mediciner mot skabb

This is a response to a written question regarding the Finnish Social Insurance Institution (Kela) reimbursements for medications used to treat scabies. It addresses concerns about access to treatment, particularly for families with children. The response likely clarifies the current reimbursement policies and may discuss any potential changes or considerations for treating contagious diseases like scabies, affecting families and healthcare providers.